Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study

Abstract

In this large population of adults tested for SARS-CoV-2 by RT-PCR after two doses of mRNA BNT162b2 vaccine, a gradual increase in the risk of infection was seen for individuals who received their second vaccine dose after at least 90 days.